These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

70 related items for PubMed ID: 7146313

  • 1. Minimal change glomerular disease in Malaysian adults and use of alternate day steroid therapy.
    Wang F, Looi LM, Chua CT.
    Q J Med; 1982; 51(203):312-28. PubMed ID: 7146313
    [Abstract] [Full Text] [Related]

  • 2. Pulse cyclophosphamide inadequately suppresses reoccurrence of minimal change nephrotic syndrome in corticoid-dependent children.
    Donia AF, Gazareen SH, Ahmed HA, Moustafa FE, Shoeib AA, Ismail AM, Khamis S, Sobh MA.
    Nephrol Dial Transplant; 2003 Oct; 18(10):2054-8. PubMed ID: 13679480
    [Abstract] [Full Text] [Related]

  • 3. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
    Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S.
    Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
    [Abstract] [Full Text] [Related]

  • 4. Natural history and response to treatment of minimal change nephrotic syndrome.
    Prabhakar KS, Prakash KC, Mani MK.
    J Assoc Physicians India; 1993 May; 41(5):263-5. PubMed ID: 8300454
    [Abstract] [Full Text] [Related]

  • 5. Adult minimal-change disease: clinical characteristics, treatment, and outcomes.
    Waldman M, Crew RJ, Valeri A, Busch J, Stokes B, Markowitz G, D'Agati V, Appel G.
    Clin J Am Soc Nephrol; 2007 May; 2(3):445-53. PubMed ID: 17699450
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
    Kashtan C, Melvin T, Kim Y.
    Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
    [Abstract] [Full Text] [Related]

  • 7. Tacrolimus as a steroid-sparing agent for adults with steroid-dependent minimal change nephrotic syndrome.
    Li X, Li H, Chen J, He Q, Lv R, Lin W, Li Q, He X, Qu L, Suya W.
    Nephrol Dial Transplant; 2008 Jun; 23(6):1919-25. PubMed ID: 17911091
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
    El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes of idiopathic membranous nephropathy in Japanese patients treated with low-dose cyclophosphamide and prednisolone.
    Eriguchi M, Oka H, Mizobuchi T, Kamimura T, Sugawara K, Harada A.
    Nephrol Dial Transplant; 2009 Oct; 24(10):3082-8. PubMed ID: 19465558
    [Abstract] [Full Text] [Related]

  • 11. Long-term treatment of minimal-change nephrotic syndrome with cyclosporin: a control biopsy study.
    Clasen W, Kindler J, Mihatsch MJ, Sieberth HG.
    Nephrol Dial Transplant; 1988 Oct; 3(6):733-7. PubMed ID: 3147414
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
    Ueda N, Takahashi K, Akioka Y, Morooka M, Ogawa A, Tsuzuki K.
    J Nephrol; 2009 Oct; 22(5):610-5. PubMed ID: 19809993
    [Abstract] [Full Text] [Related]

  • 14. Nephrotic syndrome preceding Hodgkin's disease by 42 months.
    Huisman RM, de Jong PE, de Zeeuw D, van Imhoff GW, van der Hem GK.
    Clin Nephrol; 1986 Dec; 26(6):311-3. PubMed ID: 3802598
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Long-term follow-up study of children with minimal change nephrotic syndrome].
    Takeichi S, Tazawa M, Morooka M, Minowa S, Yasaki T.
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):155-60. PubMed ID: 9134833
    [Abstract] [Full Text] [Related]

  • 17. [Primary nephrotic syndrome. Follow-up of 202 pediatric patients].
    Caletti MG, Gallo G, Zumino D, Díaz MA, Vitacco M.
    Bol Med Hosp Infant Mex; 1981 Mar; 38(3):457-72. PubMed ID: 7271977
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 20. Long-term follow-up study of IgM associated nephrotic syndrome patients: clinical outcome and prognostic indicators.
    Kurathong P, Jesdapatarakul S.
    J Med Assoc Thai; 2000 Mar; 83(3):315-24. PubMed ID: 10808687
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.